Selected research
Industry Research
Dried Blood Spot (DBS) Testing Industry Research Report 2026
Market perspective
The global Dried Blood Spot (DBS) Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Dried Blood Spot (DBS) Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Dried Blood Spot (DBS) Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Dried Blood Spot (DBS) Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Dried Blood Spot (DBS) Testing include ZRT Laboratory, Randox Laboratories, RDA Spot, Lipomic, CRL, HemaXis, EUROIMMUN, Boston Heart Diagnostics and Kurukankarti and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Dried Blood Spot (DBS) Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Dried Blood Spot (DBS) Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dried Blood Spot (DBS) Testing Market by Company
ZRT Laboratory
Randox Laboratories
RDA Spot
Lipomic
CRL
HemaXis
EUROIMMUN
Boston Heart Diagnostics
Kurukankarti
Capitainer
Dried Blood Spot (DBS) Testing Segment by Type
Testing Card
Testing Kit
Dried Blood Spot (DBS) Testing Segment by Application
HIV Test
Hepatitis C Test
Others
Dried Blood Spot (DBS) Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dried Blood Spot (DBS) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dried Blood Spot (DBS) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dried Blood Spot (DBS) Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dried Blood Spot (DBS) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Testing Card
- Testing Kit
Applications
- HIV Test
- Hepatitis C Test
- Others
Companies covered
- ZRT Laboratory
- Randox Laboratories
- RDA Spot
- Lipomic
- CRL
- HemaXis
- EUROIMMUN
- Boston Heart Diagnostics
- Kurukankarti
- Capitainer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Dried Blood Spot (DBS) Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Testing Card
- 2.2.3 Testing Kit
- 2.3 Dried Blood Spot (DBS) Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 HIV Test
- 2.3.3 Hepatitis C Test
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Dried Blood Spot (DBS) Testing Breakdown Data by Type
- 3.1 Global Dried Blood Spot (DBS) Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Dried Blood Spot (DBS) Testing Forecasted Market Size by Type (2027-2032)
4 Dried Blood Spot (DBS) Testing Breakdown Data by Application
- 4.1 Global Dried Blood Spot (DBS) Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Dried Blood Spot (DBS) Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Dried Blood Spot (DBS) Testing Market Perspective (2021-2032)
- 5.2 Global Dried Blood Spot (DBS) Testing Growth Trends by Region
- 5.2.1 Global Dried Blood Spot (DBS) Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Dried Blood Spot (DBS) Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Dried Blood Spot (DBS) Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Dried Blood Spot (DBS) Testing Market Dynamics
- 5.3.1 Dried Blood Spot (DBS) Testing Industry Trends
- 5.3.2 Dried Blood Spot (DBS) Testing Market Drivers
- 5.3.3 Dried Blood Spot (DBS) Testing Market Challenges
- 5.3.4 Dried Blood Spot (DBS) Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Dried Blood Spot (DBS) Testing Players by Revenue
- 6.1.1 Global Top Dried Blood Spot (DBS) Testing Players by Revenue (2021-2026)
- 6.1.2 Global Dried Blood Spot (DBS) Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Dried Blood Spot (DBS) Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Dried Blood Spot (DBS) Testing Head Office and Area Served
- 6.4 Global Dried Blood Spot (DBS) Testing Players, Product Type & Application
- 6.5 Global Dried Blood Spot (DBS) Testing Manufacturers Established Date
- 6.6 Global Dried Blood Spot (DBS) Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Dried Blood Spot (DBS) Testing Market Size (2021-2032)
- 7.2 North America Dried Blood Spot (DBS) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 7.4 North America Dried Blood Spot (DBS) Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Dried Blood Spot (DBS) Testing Market Size (2021-2032)
- 8.2 Europe Dried Blood Spot (DBS) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 8.4 Europe Dried Blood Spot (DBS) Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Dried Blood Spot (DBS) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Dried Blood Spot (DBS) Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Dried Blood Spot (DBS) Testing Market Size (2021-2032)
- 10.2 South America Dried Blood Spot (DBS) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 10.4 South America Dried Blood Spot (DBS) Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Dried Blood Spot (DBS) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Dried Blood Spot (DBS) Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ZRT Laboratory
- 12.1.1 ZRT Laboratory Company Information
- 12.1.2 ZRT Laboratory Business Overview
- 12.1.3 ZRT Laboratory Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.1.4 ZRT Laboratory Dried Blood Spot (DBS) Testing Product Portfolio
- 12.1.5 ZRT Laboratory Recent Developments
- 12.2 Randox Laboratories
- 12.2.1 Randox Laboratories Company Information
- 12.2.2 Randox Laboratories Business Overview
- 12.2.3 Randox Laboratories Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.2.4 Randox Laboratories Dried Blood Spot (DBS) Testing Product Portfolio
- 12.2.5 Randox Laboratories Recent Developments
- 12.3 RDA Spot
- 12.3.1 RDA Spot Company Information
- 12.3.2 RDA Spot Business Overview
- 12.3.3 RDA Spot Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.3.4 RDA Spot Dried Blood Spot (DBS) Testing Product Portfolio
- 12.3.5 RDA Spot Recent Developments
- 12.4 Lipomic
- 12.4.1 Lipomic Company Information
- 12.4.2 Lipomic Business Overview
- 12.4.3 Lipomic Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.4.4 Lipomic Dried Blood Spot (DBS) Testing Product Portfolio
- 12.4.5 Lipomic Recent Developments
- 12.5 CRL
- 12.5.1 CRL Company Information
- 12.5.2 CRL Business Overview
- 12.5.3 CRL Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.5.4 CRL Dried Blood Spot (DBS) Testing Product Portfolio
- 12.5.5 CRL Recent Developments
- 12.6 HemaXis
- 12.6.1 HemaXis Company Information
- 12.6.2 HemaXis Business Overview
- 12.6.3 HemaXis Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.6.4 HemaXis Dried Blood Spot (DBS) Testing Product Portfolio
- 12.6.5 HemaXis Recent Developments
- 12.7 EUROIMMUN
- 12.7.1 EUROIMMUN Company Information
- 12.7.2 EUROIMMUN Business Overview
- 12.7.3 EUROIMMUN Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.7.4 EUROIMMUN Dried Blood Spot (DBS) Testing Product Portfolio
- 12.7.5 EUROIMMUN Recent Developments
- 12.8 Boston Heart Diagnostics
- 12.8.1 Boston Heart Diagnostics Company Information
- 12.8.2 Boston Heart Diagnostics Business Overview
- 12.8.3 Boston Heart Diagnostics Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.8.4 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Product Portfolio
- 12.8.5 Boston Heart Diagnostics Recent Developments
- 12.9 Kurukankarti
- 12.9.1 Kurukankarti Company Information
- 12.9.2 Kurukankarti Business Overview
- 12.9.3 Kurukankarti Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.9.4 Kurukankarti Dried Blood Spot (DBS) Testing Product Portfolio
- 12.9.5 Kurukankarti Recent Developments
- 12.10 Capitainer
- 12.10.1 Capitainer Company Information
- 12.10.2 Capitainer Business Overview
- 12.10.3 Capitainer Revenue in Dried Blood Spot (DBS) Testing Business (2021-2026)
- 12.10.4 Capitainer Dried Blood Spot (DBS) Testing Product Portfolio
- 12.10.5 Capitainer Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst